The Jones Morbidity Index as an aid for community pharmacists to identify poor asthma control during the dispensing process

International Journal of Pharmacy Practice

Volumn 11, Issue 1, 2003, Pages 41-46

  Nishiyama, T ^a   Chrystyn, H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREDNISOLONE;

ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CLINICAL PHARMACY; COUGHING; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; JONES MORBIDITY INDEX; MAJOR CLINICAL STUDY; MALE; MANAGEMENT; MEDICAL RECORD; METERED DOSE INHALER; MORBIDITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROCESS MONITORING; PUBLIC HEALTH; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 0037360106     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702874     Document Type: Article

References (25)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, March 1993, Publication No 95-3659. Bethesda: National Institutes of Health, National Heart, Lung & Blood Institute; 1995.
2. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Resp J 2000;16:802-7.
3. Neville RG, Pearson MG, Richards N. et al. A cost analysis on the pattern of asthma prescribing in the UK. Eur Respir J 1999;14:605-9.
4. Pearson MG, Buchnall CE, editors. Measuring clinical outcome in asthma: a patient focused approach. London: Royal College of Physicians; 1999.
5. Jones KP, Bain DJG, Middleton M, Mullee MA. Correlates of asthma morbidity in primary care. BMJ 1992;304:361-4.
6. Jones KP, Cleary R, Hyland M. Predictive value of a simple asthma morbidity index in a general practice population. Br J Gen Pract 1999;49:23-6.
7. Dickinson J, Hutton S, Atkin A, Jones K. Reducing asthma morbidity in the community: the effect of a targeted nurse-run asthma clinic in an English general practice. Respir Med 1997;91:634-40.
8. Chrystyn H. Community care of asthma: the pharmacist as counsellor? J Pharm Pharmacol 1997;49 Suppl 3:51-4.
9. Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique using urinary salbutamol excretion as a measure of relative bioavailability to the lungs. Thorax 1993;48:607-611.
10. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London, et al. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52 Suppl 1:S1-21.
11. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993;48:603-6.
12. Barry PW, O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 1995;40:76-8.
13. Paterson IC, Crompton GK. Use of pressurised aerosols by asthmatic patients. BMJ 1976;1:76-7.
14. Crompton GK. Problems patients have using pressurised aerosol inhalers. Eur J Respir Dis 1982;119 Suppl:101-4.
15. Nimmo CJ, Chen DN, Martinusen SM, Ustad TL, Ostrow DN. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-activated devices. Ann Pharmacother 1993;27:922-7.
16. Chrystyn H, Brownlee K, Chetcuti P, Corrado OJ, Kanthapillai P, Pearson S, Tarsin W. Inhalation rates of asthmatic children (CHILD) and adults and of chronic obstructive pulmonary disease (COPD) patients through inhalers. Am J Respir Crit Care Med 2002;165:A190.
17. Farr SJ, Rowe AM, Rubsamen R, Taylor G. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax 1995;50:639-44.
18. Newman S, Steed K, Hooper G, Kallen A, Borgstrom L. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler. Pharm Res 1995;12:231-6.
19. Lenny J, Innes JA, Crompton GK. Inappropriate inhaler use; assessment of use and patient preference of seven inhalation devices. Respir Med 2000;94:496-500.
20. Osborne ML, Vollmer VM, Linton KLP, Buist AS. Characteristics of patients with asthma within a large HMO: A comparison by age and gender. Am J Respir Crit Care Med 1998;157:123-8.
21. Trawick DR, Holm C, Wieth J. Influence of gender on rates of hospitalization, hospital course, and hypercapnea in high risk patients admitted for asthma: A 10-year retrospective study at Yale-New Haven Hospital. Chest 2001;119:115-9.
22. Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo CA. Sex differences among adults presenting to the emergency department with acute asthma. Arch Intern Med 1999;159:1237-43.
23. Smith A, Nicholson K. Psychosocial factors, respiratory viruses and exacerbation of asthma. Psychoneuroendocrinology 2001;26:411-20.
24. Johannesson M, Ludvicksdottir D, Janson C. Lung function changes in relation to menstrual cycle in females with cystic fibrosis. Respir Med 2000;94:1043-6.
25. Scottish Intercollegiate Guidelines Network/British Thoracic Society. British guideline on the management of asthma. Thorax 2003;58 Suppl 1:1-97.